Zoetis Inc Stock Price, News & Analysis

Zoetis and Danone have announced a strategic partnership to drive sustainable practices in dairy farming through genetic innovation. The collaboration aims to leverage Zoetis' genetic technologies globally, focusing on animal well-being, reducing environmental impact, and promoting long-term resilience in dairy farming.

Zoetis, as Danone's preferred provider for genetic testing on dairy farms, will utilize its Dairy Wellness Profit Index® (DWP$®) from CLARIFIDE® Plus. This multi-trait animal ranking selection index helps estimate the potential lifetime profit of Holstein and Jersey cattle, incorporating critical wellness traits, production, fertility, and other factors.

The partnership aims to improve environmental, resource, and operational sustainability outcomes in dairy farming. Recent studies have shown potential benefits for sustainability, methane reduction, farm profitability, and animal welfare through genetic improvements.

Zoetis Inc. (NYSE:ZTS), a leading animal health company, has announced it will host a webcast and conference call on Monday, November 4, 2024, at 8:30 a.m. (ET) to discuss its third quarter 2024 financial results. The event will feature CEO Kristin Peck and CFO Wetteny Joseph, who will review the company's performance and address questions from financial analysts.

Investors and the public can access the live webcast through the Zoetis website at http://investor.zoetis.com/events-presentations. Pre-registration information is now available, and a replay of the webcast will be accessible on the same day.

Zoetis Inc. (NYSE:ZTS), a leading animal health company, is set to participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024. The company will be represented by CEO Kristin Peck and CFO Wetteny Joseph, who will engage in a Q&A session with analysts at 1:05 p.m. ET.

Investors and interested parties can access a live audio webcast of the session through the Zoetis investor relations website. A replay of the event will also be made available on the same platform after the conference concludes. This participation underscores Zoetis' commitment to engaging with the financial community and providing insights into its business strategies and market position.

Zoetis Inc. (NYSE:ZTS) reported strong Q2 2024 results, with revenue of $2.4 billion, up 8% (11% operational growth). Net income was $624 million ($1.37 per diluted share), down 7% and 6% respectively. Adjusted net income reached $711 million ($1.56 per diluted share), up 9% and 11% on a reported basis, and 18% and 20% operationally.

The company saw impressive growth in both U.S. (12%) and International (10% operational) segments, with strong performance in companion animal and livestock portfolios. Key drivers included osteoarthritis pain products, Simparica Trio, and dermatology offerings.

Zoetis raised its full-year 2024 guidance, projecting revenue between $9.100-$9.250 billion (9-11% operational growth) and adjusted diluted EPS of $5.78-$5.88.

Zoetis Inc. (NYSE:ZTS) has announced a $6 billion multi-year share repurchase program, approved by its Board of Directors. This program, the company's largest to date, is expected to run for up to four years and can be cancelled at any time. The announcement reflects Zoetis' strong performance, positive long-term outlook, and commitment to returning capital to shareholders.

Wetteny Joseph, Executive VP and CFO, emphasized that Zoetis remains an attractive investment opportunity due to its consistent performance and business outlook. The company's previous $3.5 billion share repurchase program, approved in December 2021, is anticipated to be completed in 2024.

Zoetis Inc. (NYSE:ZTS) has announced a time change for its second quarter 2024 financial results webcast and conference call. The event will now take place at 8:00 a.m. (ET) on Tuesday, August 6, 2024. This adjustment aims to minimize conflicts with other industry earnings announcements. Investors and the public can access the live webcast through the Zoetis website at http://investor.zoetis.com/events-presentations. The webcasting information remains unchanged, and a replay of the webcast will be available on the same day.

Zoetis (NYSE: ZTS) will host a webcast and conference call to discuss its second quarter 2024 financial results on Tuesday, August 6, 2024, at 8:30 a.m. (ET). CEO Kristin Peck and CFO Wetteny Joseph will review the results and answer questions from financial analysts. The webcast will be accessible through the Zoetis investor website, with pre-registration information available now. A replay of the webcast will be available starting the same day.

Zoetis Foundation has announced a $3 million grant to the American Red Cross, to be used over six years for global disaster relief efforts. This grant will support the Annual Disaster Giving Program, aiding both domestic and international disaster response and preparedness. In addition, Zoetis has launched a consumer matching campaign with American Humane to support pets affected by natural disasters in the U.S.

Zoetis has a decade-long partnership with American Humane, focusing on animal safety in disaster situations, and they have contributed to the care of 1.3 million animals globally between 2021-2023. The collaboration includes operating emergency vehicles stocked with Zoetis pet medications and hosting pet preparedness clinics.

The Zoetis Foundation’s support aims to bolster the Red Cross' ability to respond to disasters and help communities prepare for future crises. This initiative is part of Zoetis' broader sustainability strategy, which has made significant impacts worldwide.

Zoetis released its 2023 Sustainability Report, highlighting advancements in its 'Driven to Care' strategy. Key achievements include:

1. Increasing volunteer work by 81% to 16,611 hours.

2. Supporting 28 initiatives with $8.3 million in grants across 19 countries.

3. Launching innovative diagnostics, vaccines, and parasiticides for livestock producers.

4. Utilizing over 30% renewable electricity with on-site solar arrays at seven facilities, aiming for 100% by 2030.

5. Replacing rabies vaccine packaging plastic with paperboard, reducing PVC use by 8.0 metric tons annually.

Zoetis invested $7 million in community programs, reaching 202,000 pet owners and impacting 91,000 animals. The company also received eight awards for fostering an inclusive culture and expanded its Leading@Zoetis program to over 2,000 leaders globally.

Zoetis aims to achieve carbon neutrality by 2030, reporting 32.6% renewable electricity use, completing 38 energy efficiency projects, and reducing Scope 1 and 2 emissions by 18.9% since 2021.